TNF and inflammatory bowel disease: To further examine whether the increased TNF-α contributes to the upregulation of WISP1 in IBD patients, we detected WISP1 relative expression in intestinal mucosa from CD patients prior to and after treatment with anti-TNF-α mAb (IFX).